Mutation News and Research

RSS

New mutant rat model replicates human chronic kidney disease

Chronic kidney disease (CKD) is a major health burden affecting approximately one in ten adults globally. Even with improved treatments, many patients continue to have worsening loss of kidney function, resulting in the need for dialysis or transplantation.

27 Aug 2026

Computer model could streamline design of protein degraders

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer.

27 Aug 2026

Study reveals why diffuse midline glioma develops in brain midline regions

Scientists at St. Jude Children's Research Hospital have shown that specific brain cells respond differently to the H3.3 K27M, a mutation in the histone H3.3 protein that drives many cases of diffuse midline glioma (DMG), depending on the cell's location in the developing brain.

27 Aug 2026

FDA approves first RAS-targeted therapy for metastatic pancreatic cancer

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.

27 Aug 2026

Real-world Chinese study confirms benefits of niraparib maintenance therapy for ovarian cancer

Ovarian cancer remains one of the most lethal gynecologic malignancies worldwide, with a high risk of recurrence even after successful initial treatment.

26 Aug 2026

Scientists identify new drug target to combat airborne tuberculosis

Tuberculosis bacteria released into the air from infected individuals dry out to form infectious particles that are second only to measles in contagiousness.

26 Aug 2026

Ancient proteins revived to inspire new antimicrobial treatments

University of Oregon biologists have resurrected prehistoric proteins up to 160 million years old that carry natural antimicrobial properties.

25 Aug 2026

Yeast-based nanoparticle vaccine could make annual flu shots obsolete

The world mostly relies on an 80-year-old method for producing flu vaccines from chicken eggs - a slow, costly process that struggles to quickly adapt to new, mutant strains.

24 Aug 2026

Resistant malaria parasites become increasingly prevalent across Ethiopia

Researchers from the University of North Carolina at Chapel Hill's Institute for Global Health and Infectious Diseases, the Ethiopian Public Health Institute (EPHI), Brown University, the University of Notre Dame, and Ethiopia's Ministry of Health have found that malaria parasites carrying genetic markers associated with resistance to frontline antimalarial medicines and commonly used diagnostic tests are becoming increasingly prevalent across Ethiopia.

24 Aug 2026

Nanoparticle vaccine offers long-lasting protection against multiple flu strains

A new, nanoparticle vaccine could one day grant patients immunity to the flu with fewer trips to the doctor and without health officials correctly guessing which flu strains will become dominant each year.

24 Aug 2026

New 3D mapping technology reveals how hair follicles form over time

In a new research report, scientists at Johns Hopkins Medicine say they have developed a technology that allows them to capture a 3D molecular "snapshot" of hundreds of hair follicles as they develop and then reconstruct the fourth dimension - time - to effectively create a stop-motion animation of how this organ forms.

21 Aug 2026

AI-powered DANDELION identifies overlooked genes linked to asthma

One of the most important goals of studying genetics is to find genes that are involved with diseases. The problem is that most diseases aren't caused by a single gene or mutation.

20 Aug 2026

Review examines how medical imaging foundation models are moved toward clinical use

AI is already widely used for lesion detection, disease classification, and outcome prediction in medical imaging, but most systems remain narrowly designed for one task and depend heavily on expert-labelled data.

20 Aug 2026

NSF grant supports UH researchers to investigate how mutation rates evolve across species

A nearly $1 million grant from the National Science Foundation will allow University of Houston researchers to investigate how mutation rates evolve across species - work that could offer critical insights into cancer progression and antibiotic resistance.

19 Aug 2026

Understanding how maternal age impacts offspring health across different species

In humans and many other animals, a mother's age can affect the physical and behavioral characteristics of the next generation.

17 Aug 2026

New genetic mutations linked to malaria drug resistance discovered

Researchers searching for genetic clues to the growing problem of malaria drug resistance identified new mutations associated with the parasite's decreased susceptibility to current treatment.

17 Aug 2026

Weizmann study reveals how DNA repair enzymes choose targets

When a wound does not heal properly, it leaves a scar. Similarly, mutations – which are permanent changes to genetic code – are often the result of damaged DNA that has not been properly repaired.

14 Aug 2026

AI model predicts cancer subtype, genetic mutations, and survival outcomes across 32 solid tumors

Researchers have developed a novel AI model that can analyze a routine whole histopathology image and simultaneously predict cancer subtype, specific genetic mutations, and survival outcomes across 32 different solid cancers rather than focusing on a single cancer type.

13 Aug 2026

New heart assembloid model mimics complex valve disorders

A multi-disciplinary, multi-institution group of researchers focused their expertise in genetics, mechanics, chemistry and biology on a chip the size of a postage stamp in order to model a particular class of heart conditions.

11 Aug 2026

New protein blueprint opens door for targeted Parkinson's disease therapies

Researchers at Weill Cornell Medicine have uncovered how a key Parkinson's protein called LRRK2 shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.

10 Aug 2026